Experimental and clinical studies suggest that the HMGB1/TLR4 pathway is involved in epileptogenesis induced by neuroimmune inflammatory responses and contributes to the neuroinflammatory response of brain injury after epilepsy. This evidence concerns the gene HMGB1 and epilepsy.